Medical/Pharmaceuticals

WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received the "Special Awa...

2019-12-23 16:26 2297

Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care

SINGAPORE, Dec. 23, 2019 /PRNewswire/ -- Holmusk and National Heart Centre Singapore announced that they have extended their collaboration agreement to improve care for patients with coronary artery disease using machine learning and data analytics, untilDecember 2020. This will build upon the wo...

2019-12-23 13:43 1928

iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

HYDERABAD, India, Dec. 23, 2019 /PRNewswire/ -- iView Therapeutics Inc. today announced that the first patient has been dosed in the Phase 2 IVIEW-1201-01-AIC clinical trial program assessing the efficacy of IVIEW-1201 in patients (age ≥15 years) with Acute Adenoviral Conjunctivitis. First subjec...

2019-12-23 08:42 1865

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chroni...

2019-12-23 08:33 1349

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Demonstrates Evoke® ECAP-Controlled Closed-Loop SCS Provides Statistically Superior Pain Relief Compared to Open-Loop SCS ARTARMON, Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announcedThe Lancet Neurology journal published results from the U.S. P...

2019-12-21 07:48 1739

InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018

BEIJING, Dec. 20, 2019 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the Company has obtained IND (Investigational New Drug) clearan...

2019-12-20 18:21 2397

HISKY, a leader in the innovative detection technology of liver health, launches the new brand iLivTouch

BEIJING, Dec. 20, 2019 /PRNewswire/ -- Recently, Wuxi Hisky Medical Technologies Co., Ltd. (hereinafter referred to as "HISKY") has successfully launched its new brand iLivTouch based on the MigTE technology. "On the increasingly competitive market, cycles of technological innovation are key to ...

2019-12-20 15:49 990

Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC

SEONGNAM, South Korea, Dec. 19, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company filed an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) and the Ministry...

2019-12-20 10:19 1287

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China

TINLEY PARK, Illinois, Dec. 19, 2019 /PRNewswire/ -- Hematogenix® announces the opening of their newest facility inShanghai, China furthering their commitment to be a global leader in the field of cancer research and diagnostic testing. China's growing population is attractive to the pharmaceutica...

2019-12-19 22:07 2092

4G Clinical Launches Innovative Clinical Supply Software Leveraging Natural Language Processing (NLP)

4C Supply™ Empowers Supply Professionals to Build and Analyze Multiple Supply Models Themselves, Providing Speed, Simplicity and Control over Supply Decisions WELLESLEY, Mass., Dec. 19, 2019 /PRNewswire/ -- 4G Clinical today announced the launch of 4C Supply™, a cutting-edge clinical supply optim...

2019-12-19 21:20 1491

Merck Licenses Foundational CRISPR Integration Technology to Promega

- Gives scientists a new view into natural cell activity, accelerating drug development DARMSTADT, Germany, Dec. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingPromega Corp., a global life science manufact...

2019-12-19 21:00 2409

Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020

* State-of-the-art manufacturing facility will support clinical and commercial production of cell therapies for thousands of patients annually worldwide * Global commercial-scale facility is designed to comply with cGMP guidelines in the U.S.,Europe and Asia * Facility will integrate digita...

2019-12-19 20:00 1264

Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems

GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for...

2019-12-19 18:27 15217

Pentax Medical Remains Committed to Endoscopic Ultrasound Business

TOKYO, Dec. 19, 2019 /PRNewswire/ -- PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscopy portfolio. The recent launch of the PENTAX Medical EUS/EBUS-J10* line-up is experiencing unmatched recognition by the endoscopy community....

2019-12-19 16:14 1820

Asieris Wins Questex's Fierce Innovation Awards - Life Sciences Edition 2019

SHANGHAI, Dec. 19, 2019 /PRNewswire/ -- Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, announced today that it has been selected as a winner in this year's Fierce Innovation ...

2019-12-19 13:51 2764

Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed an exclusive license deal with US-based Onconova Therapeutics (NASDAQ: ONTX), securing commercialisation rights to a new therapy for the treatment of Myelodysplastic Syndrome...

2019-12-18 22:00 2785

health.ESDlife Enlightens Your Healthy Living with Diversified Offerings

HONG KONG, Dec. 18, 2019 /PRNewswire/ -- An e-commerce brand of ESDlife, under the umbrella of renowned multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001),health.ESDlife (https://health.esdlife.com/ ) Hong Kong's first and only online platf...

2019-12-18 19:22 1927

Amaris B. Clinic Medical Director: Gynecomastia is Prevailing in Older Men, Especially Those Taking Prescription Medications

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Dr Ivan Puah, the medical director of Amaris B. Clinic, who has been performing gynecomastia since 2005 and is accredited by the Ministry ofSingapore to perform surgical body sculpting treatments such as liposuction, is seeing an uprise in older male pa...

2019-12-18 19:12 2028

Mayapada Healthcare Group named Indonesia Emerging Hospital of the Year by Frost & Sullivan

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Mayapada Healthcare Group was recognized with the 2019 Frost & Sullivan Indonesia Emerging Hospital of the Year award at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held at The St. Regis Singapore on 14 November. Norazah Bachok,...

2019-12-18 14:54 1046

Össur Celebrates 20 Years as a Publicly Traded Company

President and CEO Jon Sigurdsson Rings Nasdaq Closing Bell on December 16 NEW YORK, Dec. 18, 2019 /PRNewswire/ -- To mark Össur's 20th anniversary as a publicly traded company,Jon Sigurdsson, the company's President and CEO, rang the closing bell at the Nasdaq MarketSite inNew York's Times Squar...

2019-12-18 03:26 7185
1 ... 602603604605606607608 ... 610

Week's Top Stories